Literature DB >> 15672358

Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma.

Xavier León1, Ignasi Gich, César Orús, María Del Prado Venegas, Juan Ramón Gras, Miquel Quer.   

Abstract

BACKGROUND: Prognostic models need to be tested in external validation studies to assess generalizability. Recursive partitioning analysis (RPA), a prognostic system based on the creation of a classification tree, has been proposed as a classification method in patients with head and neck carcinoma. The aim of this study was to compare the RPA and Union Internationale Contre le Cancer (UICC) TNM classification systems in patients with head and neck carcinoma treated consecutively in a single center.
METHODS: A total of 2166 patients with carcinomas of the oral cavity, oropharynx, hypopharynx, and larynx was classified according to both the RPA and the TNM classification systems, and the results were compared. The endpoints considered were observed survival and survival free of locoregional tumor. The two methods of classification were evaluated objectively by use of measures of intrastage homogeneity (hazard consistency), interstage heterogeneity (hazard discrimination), predictive power (outcome prediction), and patient distribution between stages (balance).
RESULTS: When the endpoint considered was observed survival, there were no clinically relevant differences between the two classifications. However, when the endpoint was locoregional control, the RPA system was sensitive to the type of treatment used, and it was not generalizable.
CONCLUSIONS: To evaluate generalizability, new classification proposals need external validation studies that objectively measure the quality of the model. The performance of the RPA system was not reproducible in our cohort of patients when the endpoint evaluated was locoregional control. 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15672358     DOI: 10.1002/hed.20148

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  3 in total

1.  Prospective imaging assessment of mortality risk after head-and-neck radiotherapy.

Authors:  Benjamin J Moeller; Vishal Rana; Blake A Cannon; Michelle D Williams; Erich M Sturgis; Lawrence E Ginsberg; Homer A Macapinlac; J Jack Lee; K Kian Ang; K S Clifford Chao; Gregory M Chronowski; Steven J Frank; William H Morrison; David I Rosenthal; Randal S Weber; Adam S Garden; Scott M Lippman; David L Schwartz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-18       Impact factor: 7.038

2.  DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy.

Authors:  Benjamin J Moeller; John S Yordy; Michelle D Williams; Uma Giri; Uma Raju; David P Molkentine; Lauren A Byers; John V Heymach; Michael D Story; J Jack Lee; Erich M Sturgis; Randal S Weber; Adam S Garden; K Kian Ang; David L Schwartz
Journal:  Clin Cancer Res       Date:  2011-02-24       Impact factor: 12.531

3.  Evidence-based review of treatment options for patients with glottic cancer.

Authors:  A De Virgilio; F Bussu; M De Vincentiis
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-08       Impact factor: 2.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.